Market Value361,134,000
Total Holdings53
File Date2019-05-15
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
FOMX / Foamix Pharmaceuticals Ltd.
BOLD / Boundless Bio, Inc.
EPZM / Epizyme Inc
NVTA / Invitae Corporation
FBIO / Fortress Biotech, Inc.
PTCT / PTC Therapeutics, Inc.
VRDN / Viridian Therapeutics, Inc.
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
FGEN / FibroGen, Inc.
SIOX / Sio Gene Therapies Inc.
FENC / Fennec Pharmaceuticals Inc.
CMRX / Chimerix, Inc.
CBAY / CymaBay Therapeutics, Inc.
CDTX / Cidara Therapeutics, Inc.
PTE / PolarityTE Inc
ESTA / Establishment Labs Holdings Inc.
ODT / Odonate Therapeutics Inc
ABEO / Abeona Therapeutics Inc.
LOXO / Loxo Oncology, Inc.
XNCR / Xencor, Inc.
CTIC / CTI BioPharma Corp
CMTA / Clementia Pharmaceuticals Inc.
HZNP / Horizon Therapeutics Plc
COLL / Collegium Pharmaceutical, Inc.
APLS / Apellis Pharmaceuticals, Inc.
IMGN / ImmunoGen, Inc.
ZYME / Zymeworks Inc.
LJPC / La Jolla Pharmaceutical Co.
PBYI / Puma Biotechnology, Inc.
ACOR / Acorda Therapeutics, Inc.
KURA / Kura Oncology, Inc.
MRTX / Mirati Therapeutics, Inc.
AXGN / Axogen, Inc.
QURE / uniQure N.V.
THOR / Synthorx Inc
SBBP / Strongbridge Biopharma plc
MGTA / Magenta Therapeutics Inc
AMRN / Amarin Corporation plc - Depositary Receipt (Common Stock)
TCDA / Tricida Inc
US28249H1041 / Eidos Therapeutics, Inc.
ARQL / ArQule, Inc.
ASRT / Assertio Holdings, Inc.
CRNX / Crinetics Pharmaceuticals, Inc.
TVTX / Travere Therapeutics, Inc.
ATXI / Avenue Therapeutics, Inc.
0HBB / Aimmune Therapeutics Inc
LQDA / Liquidia Corporation
DERM / Journey Medical Corporation
PLX / Protalix BioTherapeutics, Inc.
DCPH / Deciphera Pharmaceuticals, Inc.
ETON / Eton Pharmaceuticals, Inc.
AVTX / Avalo Therapeutics, Inc.
MGNX / MacroGenics, Inc.
VKTX / Viking Therapeutics, Inc.
ACAD / ACADIA Pharmaceuticals Inc.
SWAV / Shockwave Medical, Inc.
BLRX / BioLineRx Ltd. - Depositary Receipt (Common Stock)
CARA / Cara Therapeutics, Inc.
BPMC / Blueprint Medicines Corporation
HROW / Harrow, Inc.
XOMA / XOMA Royalty Corporation
CYTK / Cytokinetics, Incorporated
CPRX / Catalyst Pharmaceuticals, Inc.
OCUL / Ocular Therapeutix, Inc.
CDXS / Codexis, Inc.
SGMO / Sangamo Therapeutics, Inc.
TGTX / TG Therapeutics, Inc.